151 related articles for article (PubMed ID: 22222492)
1. Lower serum paraoxonase-1 activity is related to linoleic and docosahexanoic fatty acids in type 2 diabetic patients.
Rasic-Milutinovic Z; Popovic T; Perunicic-Pekovic G; Arsic A; Borozan S; Glibetic M
Arch Med Res; 2012 Jan; 43(1):75-82. PubMed ID: 22222492
[TBL] [Abstract][Full Text] [Related]
2. The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation.
Ebtehaj S; Gruppen EG; Parvizi M; Tietge UJF; Dullaart RPF
Cardiovasc Diabetol; 2017 Oct; 16(1):132. PubMed ID: 29025405
[TBL] [Abstract][Full Text] [Related]
3. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
4. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
Sözmen EY; Sözmen B; Delen Y; Onat T
Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure.
Asselin C; Ducharme A; Ntimbane T; Ruiz M; Fortier A; Guertin MC; Lavoie J; Diaz A; Levy E; Tardif JC; Des Rosiers C
Redox Biol; 2014; 2():148-55. PubMed ID: 24494189
[TBL] [Abstract][Full Text] [Related]
6. The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome.
Dullaart RP; Kwakernaak AJ; Dallinga-Thie GM
Atherosclerosis; 2013 Sep; 230(1):6-11. PubMed ID: 23958245
[TBL] [Abstract][Full Text] [Related]
7. Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Poreba M; Rostoff P; Siniarski A; Mostowik M; Golebiowska-Wiatrak R; Nessler J; Undas A; Gajos G
Cardiovasc Diabetol; 2018 Feb; 17(1):29. PubMed ID: 29452596
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects.
Dullaart RP; Otvos JD; James RW
Clin Biochem; 2014 Aug; 47(12):1022-7. PubMed ID: 24769273
[TBL] [Abstract][Full Text] [Related]
9. Associations between myeloperoxidase and paraoxonase-1 and type 2 diabetes in patients with ischemic heart disease.
Nessler K; Grzybczak R; Nessler M; Zalewski J; Gajos G; Windak A
BMC Cardiovasc Disord; 2022 Dec; 22(1):521. PubMed ID: 36463116
[TBL] [Abstract][Full Text] [Related]
10. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.
Kappelle PJ; Bijzet J; Hazenberg BP; Dullaart RP
Arch Med Res; 2011 Apr; 42(3):219-25. PubMed ID: 21722818
[TBL] [Abstract][Full Text] [Related]
11. Association of paraoxonase 1 activity and insulin resistance models in type 2 diabetes mellitus: Cross-sectional study.
Adiga U; Banawalikar N; Menambath DT
J Chin Med Assoc; 2022 Jan; 85(1):77-80. PubMed ID: 35006126
[TBL] [Abstract][Full Text] [Related]
12. Circulating linoleic acid and alpha-linolenic acid and glucose metabolism: the Hoorn Study.
Cabout M; Alssema M; Nijpels G; Stehouwer CDA; Zock PL; Brouwer IA; Elshorbagy AK; Refsum H; Dekker JM
Eur J Nutr; 2017 Sep; 56(6):2171-2180. PubMed ID: 27418185
[TBL] [Abstract][Full Text] [Related]
13. Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control.
Sözmen B; Delen Y; Girgin FK; Sözmen EY
Clin Biochem; 1999 Aug; 32(6):423-7. PubMed ID: 10667477
[TBL] [Abstract][Full Text] [Related]
14. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
[TBL] [Abstract][Full Text] [Related]
15. Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients.
Pelikánová T; Kazdová L; Chvojková S; Base J
Metabolism; 2001 Dec; 50(12):1472-8. PubMed ID: 11735096
[TBL] [Abstract][Full Text] [Related]
16. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Oxidative Stress Parameters and Inflammatory Markers in Ischemic Stroke Patients.
Chehaibi K; Trabelsi I; Mahdouani K; Slimane MN
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2585-2593. PubMed ID: 27474112
[TBL] [Abstract][Full Text] [Related]
18. Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients.
Jacobo-Cejudo MG; Valdés-Ramos R; Guadarrama-López AL; Pardo-Morales RV; Martínez-Carrillo BE; Harbige LS
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587203
[TBL] [Abstract][Full Text] [Related]
19. Serum paraoxonase-1 enzyme activities and oxidative stress levels in patients with esophageal squamous cell carcinoma.
Sehitogulları A; Aslan M; Sayır F; Kahraman A; Demir H
Redox Rep; 2014 Sep; 19(5):199-205. PubMed ID: 24731121
[TBL] [Abstract][Full Text] [Related]
20. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
